Oct 7 (Reuters) - the eu medicines agency (EMA) noted on Thursday it had accepted U.S. drugmaker Merck & Co Inc's manufacturing web site in West factor, Pennsylvania to make Johnson & Johnson's COVID-19 vaccine.
earlier this year, Merck agreed to make its rival's shot, after scrapping two of its own experimental COVID-19 vaccines.
The U.S. executive at the moment invoked the protection creation Act to support equip two Merck plant life to make the J&J vaccine.
The EMA said Merck's site, to develop into operational immediately, was expected to guide the persevered give of J&J's COVID-19 vaccine within the European Union. (Reporting by using Manas Mishra in Bengaluru; editing by Shinjini Ganguli)
0 Comments